The complementary role of drug, ablation and device in the electrical therapy of atrial fibrillation

被引：3

作者：

Capucci, A ^{[1
]}

Villani, GQ ^{[1
]}

Marrazzo, N ^{[1
]}

Piepoli, M ^{[1
]}

机构：

[1] Osped Civile, Div Cardiol, I-29100 Piacenza, Italy

来源：

EUROPEAN HEART JOURNAL SUPPLEMENTS | 2001年 / 3卷 / 0P期

关键词：

atrial fibrillation; antiarrhythmic drugs; atrial cardioversion; radiofrequency ablation; dual chamber pacing; implantable cardioverter-defibrillator;

D O I：

10.1016/S1520-765X(01)90072-0

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Atrial fibrillation (AF) is the most common sustained arrhythmia. Current therapies, including pharmacological treatment, radiofrequency ablation and implantable devices, showed significant limitation when used alone. Recently a number of combined therapies (hybrid therapy approach) were suggested. Radiofrequency ablation may improve the efficacy of drugs, pacing and automatic internal defibrillators. Antiarrhythmic drugs may play a similar role, enhancing preventive atrial pacing effectiveness as well as sinus rhythm restoration capabilities of cardioversion shocks and antitachycardia pacing. The availability of a wide range of therapeutic options suggests that the approach to the treatment of AF needs to be selected on an individual basis. (C) 2001 The European Society of Cardiology.

引用

页码：P47 / P52

页数：6

共 40 条

[1] PREVENTION OF SYMPTOMATIC RECURRENCES OF PAROXYSMAL ATRIAL-FIBRILLATION IN PATIENTS INITIALLY TOLERATING ANTIARRHYTHMIC THERAPY - A MULTICENTER, DOUBLE-BLIND, CROSSOVER STUDY OF FLECAINIDE AND PLACEBO WITH TRANSTELEPHONIC MONITORING [J].